Home › Funds › Millennium Management › SABS
Millennium Management position in SABS
SAB BIOTHERAPEUTICS INC · Health Care
Latest position (Q2 2026)2.75M sh
Reported value held$10.72M
Portfolio Weight0.00%
First reportedQ2 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 64.22K | $93.00K | New |
| Q3 2022 | 38.55K | $27.00K | Reduce |
| Q1 2024 | 54.05K | $245.39K | New |
| Q2 2024 | 52.78K | $163.63K | Reduce |
| Q3 2024 | 51.95K | $140.25K | Reduce |
| Q4 2024 | 29.41K | $112.35K | Reduce |
| Q1 2025 | 16.35K | $22.07K | Reduce |
| Q4 2025 | 324.09K | $1.21M | New |
| Q1 2026 | 3.03M | $11.62M | Add |
| Q2 2026 | 2.75M | $10.72M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SABS
- Balyasny Asset Management 3.76M sh · $14.67M · Q2 2026
- BlackRock Inc 3.07M sh · $11.96M · Q2 2026
- Vanguard Group 1.85M sh · $6.91M · Q4 2025
- Geode Capital Management 1.28M sh · $4.98M · Q2 2026
- UBS Group AG 365.88K sh · $1.43M · Q2 2026
- Northern Trust Corp 362.49K sh · $1.41M · Q2 2026
- Two Sigma Investments 214.63K sh · $837.07K · Q2 2026
- Goldman Sachs Group 191.31K sh · $746.09K · Q2 2026
- Citadel Advisors 143.80K sh · $560.81K · Q2 2026
- BNY Mellon 107.85K sh · $420.60K · Q2 2026
- Charles Schwab Investment Management 105.68K sh · $412.16K · Q2 2026